| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_12a9e9ce63eb0bbf3658453fb50a6d9b |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-70585
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-705
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-112 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2884
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57411
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57419
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57484
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57446
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-566 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-566
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 |
| filingDate |
1993-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a7f3202f6136b3a2470f41fc085047c4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d50e0a2421a283c6f3b8e81ee8c4651
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_26124388e5cf2eb67e5b01a377f8e727
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a211aedc5a8ab38fc0d09e926e928ebf |
| publicationDate |
1995-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
DE-4321944-A1 |
| titleOfInvention |
Methods for the diagnosis and analysis of colon carcinomas |
| abstract |
The invention relates to a method for the diagnosis outside the human body and/or analysis of colon carcinomas. The method is characterised in that it is based on the detection and/or quantification of the expression of variant CD44 molecules, in particular those CD44 variants which express the exon v6. The method can expediently be carried out using antibodies on samples, for example tissue sections from biopsy material, in particular using antibodies against an epitope encoded by the exon v6. The method has diagnostic and prognostic value. It makes it possible to estimate the tumour stage on the basis of a molecular marker and thus provides information on the overall survival time and the risk of metastasis. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0833948-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7763244-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7132509-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1655382-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0833948-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1655382-A2 |
| priorityDate |
1993-07-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |